Amarantus BioScience Holdings, Inc.
AMBS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$36.84K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $36,841.00 |
|---|---|
| Enterprise Value | $19.16 Million |
| Earnings per Share | $-0.01 |
| Beta | -4.42 |
| Outstanding Shares | 630,407,411 |
Return
| Return on Equity | 7.10% |
|---|---|
| Return on Assets | -17.16% |
| Return on Invested Capital | 7.30% |
Valuation & Multiples
| P/E Ratio | -0.01 |
|---|---|
| PEG | 0.01 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 198.34 |
| Enterprise Value to EBIT | -10.63 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 1 |
| Debt to Equity | -0.77 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Amarantus BioScience Holdings, Inc.
12 employees
CEO: John Wesley Commissiong
Amarantus BioScience Holdings, Inc. operates as a biopharmaceutical firm, concentrating on creating innovative diagnostic tools and therapeutic solutions. Its primary focus areas encompass neurological disorders, psychiatric conditions, ...